Status:
COMPLETED
Complications and Mortality Following Emergency Digestive Surgery During the COVID-19 Pandemic
Lead Sponsor:
Hospital Universitari de Bellvitge
Collaborating Sponsors:
Institut d'Investigació Biomèdica de Bellvitge
Conditions:
Covid19
Surgery--Complications
Eligibility:
All Genders
18+ years
Brief Summary
A multi-centre, observational cohort study will be carried out in consecutive patients operated on for urgent digestive pathology. Two cohorts will be defined: the 'pandemic' cohort, which will includ...
Detailed Description
COVIDCIR is an observational, multicenter, cohorts' study of patients undergoing emergency/urgent gastrointestinal surgery during the period of maximum impact of the COVID-19 pandemic in Spain (from M...
Eligibility Criteria
Inclusion
- Patients ≥18 years, both genders, and operated on for urgent/emergency gastrointestinal pathology.
Exclusion
- Patients who have undergone a scheduled surgical intervention or patients operated on by a service other than General and Digestive Surgery.
- Patients \< 18 years old
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2020
Estimated Enrollment :
5307 Patients enrolled
Trial Details
Trial ID
NCT04479150
Start Date
March 1 2020
End Date
August 31 2020
Last Update
February 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitari de Bellvitge
L'Hospitalet de Llobregat, Barcelona, Spain, 08907